Nasal vaccine combats bird flu infection in rodents
Researchers at WashU Medicine have developed a nasal vaccine against the highly pathogenic H5N1 avian influenza virus, or bird flu, which has jumped from wild birds to livestock to humans. When tested in rodents, the vaccine elicited a strong immune response and prevented infections in animals exposed to H5N1.
Immunotherapy reduces plaque in arteries of mice
An antibody-based immunotherapy reduces plaque in the arteries of mice, offering a potential new strategy to treat cardiovascular disease, according to a study led by WashU Medicine researchers.
Imaging technique can reduce benign breast biopsies by 25%
Ultrasound-guided diffuse optical tomography reduces breast biopsies by 25% in a new study from researchers at Washington University in St. Louis.
Tapping the engines of cellular electrochemistry and forces of evolution
Biomedical engineers at Washington University in St. Louis have outlined how properties of biological condensates may serve as engines to power electrochemical reactions at a microscale.
Breathing disruptions during sleep widespread in newborns with severe spina bifida
A multi-center study led by researchers at WashU Medicine and Michigan Medicine found that breathing problems during sleep are widespread among newborns with a severe form of spina bifida and could be a promising target for early interventions to improve the babies’ neurodevelopment.
Breath carries clues to gut microbiome health
Researchers at WashU Medicine and Children’s Hospital of Philadelphia have shown that disease-associated bacteria in the gut can be detected through exhaled breath. The findings could pave the way for a rapid, non-invasive breath test to assess gut microbiome health.
WashU named Focused Ultrasound Center of Excellence
Washington University in St. Louis has been recognized as a Focused Ultrasound Center of Excellence by the Focused Ultrasound Foundation.
Reviving antibiotics with two-faced nanoparticles
A team led by Yan Yu of Washington University in St. Louis developed a double-pronged approach to fighting antibiotic resistance.
WashU startups attract record-setting $1.7 billion in private-sector investment over past year
Startups built on WashU discoveries attracted a record $1.7 billion in private-sector investment over the past year, accelerating the commercialization of WashU innovations into life-changing diagnostics, therapeutics and medical devices.
New ALS drug stabilizes decline with improved strength, mobility for some
Long-term use of a new drug, toferson, approved by the FDA for a rare genetic form of ALS, delays symptom progression and death and leads to stabilization or improvement in some patients, according to a study by WashU Medicine researchers and collaborators.
Older Stories